Cassava Sciences Inc (SAVA)

2.59 +0.25 (+10.68%) USD  |  NASDAQ  |  Dec 26, 16:00
2.62 +0.03 (+1.16%) Pre-Market: 08:10
More

Cassava Sciences Research and Development Expense (Quarterly): 17.68M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Bristol-Myers Squibb Co 2.374B
BridgeBio Pharma Inc 120.44M
Seelos Therapeutics Inc 0.966M
Alnylam Pharmaceuticals Inc 270.93M
EyePoint Pharmaceuticals Inc 29.54M